Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating heart failure with preserved ejection fraction using modified forms of trimetazidine

Methods of treating heart failure with preserved ejection fraction using modified forms of trimetazidine

US Patent 12502389 · Granted Dec 23, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating rheumatic diseases using trimetazidine-based compounds2025
Methods of treating kidney conditions using modified forms of trimetazidine2025
Methods of treating non-obstructive hypertrophic cardiomyopathy using modified f2025
Methods of treating non-obstructive hypertrophic cardiomyopathy using modified f2025
Methods of treating heart failure with hibernating myocardium using modified for2024
Methods of treating heart failure with hibernating myocardium using modified for2024
Methods of treating heart failure with reduced ejection fraction using modified 2024
Methods of treating heart failure with reduced ejection fraction using modified 2024
Methods of treating kidney conditions using modified forms of trimetazidine2024
Methods of treating heart failure with preserved ejection fraction using modifie2023
Methods of treating heart failure with preserved ejection fraction using modifie2023
Methods of treating non-obstructive hypertrophic cardiomyopathy using modified f2023